---
title: "ABERMAN MICHAEL S — Ownership Dossier"
canonical: https://whiteintel.dev/entity/76fbfc4e-6b03-51ef-b7ad-87b6893de285
json: https://whiteintel.dev/api/public/dossier/76fbfc4e-6b03-51ef-b7ad-87b6893de285
identifier: sec:0001487767
jurisdiction: US
risk: Low
source: WhiteIntel corporate-ownership graph
---

# ABERMAN MICHAEL S

**Type:** Company  
**Jurisdiction:** [US](https://whiteintel.dev/jurisdictions/us)  
**Identifier:** `sec:0001487767`  
**Risk level:** Low  
**Canonical dossier:** https://whiteintel.dev/entity/76fbfc4e-6b03-51ef-b7ad-87b6893de285  
**Structured JSON / MCP:** https://whiteintel.dev/api/public/dossier/76fbfc4e-6b03-51ef-b7ad-87b6893de285  

## Ownership & control

### Holdings / subsidiaries

- **REGENERON PHARMACEUTICALS, INC.** (officer) — https://whiteintel.dev/entity/4c94c46c-66cf-5651-b60a-46242ce9fe83

---

_This is the markdown-for-agents view of the WhiteIntel dossier for **ABERMAN MICHAEL S**. Human view: https://whiteintel.dev/entity/76fbfc4e-6b03-51ef-b7ad-87b6893de285 · Structured JSON: https://whiteintel.dev/api/public/dossier/76fbfc4e-6b03-51ef-b7ad-87b6893de285._

_Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership. Every claim carries a source; an absent edge means "not yet observed in current sources", not "does not exist"._